Higher expression in poorly differentiated and in metastatic tumors suggests that S100A3 plays a role in drug resistance, since poorly differentiated tumors as well as metastatic ones are usually more resistant to chemotherapy than are well differentiated primary tumors. The gene discussed is S100A3; the disease is metastatic neoplasm.